Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SERPINA7P1 is classified as a polymorphic pseudogene within the serpin superfamily, specifically corresponding to the clade A (alpha-antiproteinase-like) group[3][5][8]. Unlike functional serpins, pseudogenes do not encode proteins due to genetic disruptions or mutations that prevent translation[3][5]. SERPINA7P1’s sequence is related to the functional gene SERPINA7 (thyroxine-binding globulin), which is a transporter protein; however, SERPINA7P1 itself does not function in thyroid hormone transport or protease inhibition[5][2][8]. It has no documented biological role, protein product, or significance as a therapeutic or diagnostic marker. Most available information notes that this pseudogene occurs in the human genome as a non-coding, non-functional allele in some populations[3][8]. There is no evidence of SERPINA7P1 being a therapeutic target, biomarker, or having clinical relevance[3][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serpin family A member 7 pseudogene 1 (SERPINA7P1).